Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome

Prenatal Diagnosis

Volumn 23, Issue 13, 2003, Pages 1073-1076

  Muller, Françoise ^a   Dreux, Sophie ^a   Lemeur, Alain ^b   Sault, Corinne ^c   Desgrès, Jean ^d   Bernard, Marguerite Anne ^e   Giorgetti, Claude ^f   Lemay, Catherine ^g   Mirallié, Sophie ^h   Beauchet, Alain ⁱ  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b LABORATOIRE D EYLAU   (France)

^c LMM Laboratoire Marcel Merieux   (France)

^d DIJON UNIVERSITY HOSPITAL   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f Laboratoire Caparros Giorgetti   (France)

^g AMIENS UNIVERSITY HOSPITAL   (France)

^h CENTRE HOSPITALIER   (France)

ⁱ HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Amniocentesis; Down syndrome screening; ICSI; IVF; Maternal serum markers; Medically assisted reproduction; Trisomy 21

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DOWN SYNDROME; FEMALE; FERTILIZATION IN VITRO; FETUS; HIGH RISK PATIENT; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MATERNAL BLOOD; PARENT COUNSELING; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REPRODUCTION; SCREENING TEST; SECOND TRIMESTER PREGNANCY;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; COUNSELING; DOWN SYNDROME; ESTRIOL; FEMALE; FERTILIZATION IN VITRO; FRANCE; HUMANS; LABORATORIES; MEDICAL RECORDS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 9144249185     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.756     Document Type: Article

References (20)

1. Arbuzova S, Cuckle H, Mueller R, Sehmi I. 2001. Familial Down syndrome: evidence supporting cytoplasmic inheritance. Clin Genet 60: 456-462.
2. Bar-Hava I, Ytzhak M, Krissi H, et al. 2001. Triple-test screening in in vitro fertilization pregnancies. J Assist Reprod Genet 18: 226-229.
3. Barkai G, Goldman B, Ries L, Chaki R, Dor J, Cuckle H. 1996. Down's syndrome screening marker levels following assisted reproduction. Prenat Diagn 16: 1111-1114.
4. Cuckle H. 1995. Improved parameters for the risk estimation in Down's syndrome screening. Prenat Diagn 15: 1057-1065.
5. Frishman GN, Canick JA, Hogan JW, Hackett RJ, Kellner LH, Saller Jr DN. 1997. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies. Obstet Gynecol 90: 98-101.
6. Heinonen S, Ryynanen M, Kirkinen P, Hippelainen M, Saarikoski S. 1996. Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening. Fertil Steril 66: 398-403.
7. Lam YH, Yeung WS, Tang MH, Ng EH, So WW, Ho PC. 1999. Maternal serum alpha-fetoprotein and human chorionic gonadotropin in pregnancies conceived after intracytoplasmic sperm injection and conventional in vitro fertilization. Hum Reprod 14: 2120-2123.
8. Maymon R, Dreazen E, Rozinsky S, Bukovsky I, Weinraub Z, Herman A. 1999. Comparison of nuchal translucency measurement and midgestation serum screening in assisted reproduction versus naturally conceived singleton pregnancies. Prenat Diagn 19: 1007-1011.
9. Maymon R, Shulman A. 2001. Comparison of triple serum screening and pregnancy outcome in oocyte donation versus IVF pregnancies. Hum Reprod 16: 691-695.
10. Maymon R, Shulman A. 2002. Serial first- and second-trimester Down's syndrome screening tests among IVF-versus naturally conceived singletons. Hum Reprod 17: 1081-1085.
11. Meyers C, Adam R, Dungan J, Prenger V. 1997. Aneuploidy in twin gestations: When is maternal age advanced? Obstet Gynaecol 89: 248-251.
12. Muller F, Dreux S, Dupoizat H, et al. 2003. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity. Prenat Diagn 23: 331-335.
13. Neveux LM, Palomäki GE, Knight GJ, Haddow JE. 1996. Multiple marker screening for Down syndrome in twin pregnancies. Prenat Diagn 16: 29-34.
14. Orlandi F, Rossi C, Allegra A, et al. 2002. First-trimester screening with free β-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn 22: 718-721.
15. Perheentupa A, Ruokonen A, Tuomivaara L, Ryynanen M, Martikainen H. 2002. Maternal serum beta-HCG and alpha-fetoprotein concentrations in singleton pregnancies following assisted reproduction. Hum Reprod 17: 794-797.
16. Raty R, Virtanen A, Koskinen P, et al. 2002. Serum free beta-HCG and alpha-fetoprotein levels in IVF, ICSI and frozen embryo transfer pregnancies in maternal mid-trimester serum screening for Down's syndrome. Hum Reprod 17: 481-484.
17. Ribbert LS, Kornmann LH, De Wolf BT, et al. 1996. Maternal serum screening for fetal Down syndrome in IVF pregnancies. Prenat Diagn 16: 35-38.
18. Spencer K, Salonen R, Muller F. 1994. Down's syndrome screening in multiple pregnancies using alpha-fetoprotein and free beta-hCG. Prenat Diagn 14: 537-542.
19. Wald NJ, White N, Morris JK, Huttly WJ, Canick JA. 1999. Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening. Br J Obstet Gynaecol 106: 1304-1306.
20. Wojdemann KR, Larsen SO, Shalmi A, Sundberg, Christiansen M, Tabor A. 2001. First-trimester screening for Down syndrome and assisted reproduction: no basis for concern. Prenat Diagn 21: 563-565.